FemBloc Permanent Contraceptive System

Product Overview

Development Status: Active Development

Target: Female

Mode: Non-hormonal

Delivery Type: Intrauterine

Duration Type: Permanent

Description: A degradable biopolymer is sent through a catheter-based delivery system placed in the uterus to permanently block the fallopian tubes after several weeks.

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Early Development

Project Stage: Phase I

Status Details:
  • IDE approval granted by FDA in 2016 for U.S. prospective, multi-center clinical trial of FemBloc beginning in early 2017.

Download Product Report